TF and non-small cell lung carcinoma: In line with previous findings, we detected a median cfDNA concentration of 24.9 ng/mL of plasma (range 3.7-704.3 ng/mL) and a median TF of 29.8% (Q1-Q3: 12.5–48%) in our case series, whereas in NSCLC only 20% of cases have TF exceeding 10%30.